We invest in ideas and commercialise results

On this page

We take commercially promising research and build companies that enterprise and innovate, creating positive societal, economic and environmental change.

We offer a combination of expertise, skills and facilities to help our spinouts succeed, and connect companies with funding networks and guide them in protecting and enhancing intellectual property.

“We’re very grateful for the assistance provided by the University of Dundee when establishing STAR-Dundee. The University’s initial guidance helped us to grow to be a very successful internationally renowned organization, without taking on any external funding.”

Stuart Mills, CEO, STAR-Dundee

University of Dundee top in Scotland for spinouts

The University of Dundee has been named the best seat of learning in Scotland for supporting spinout businesses, according to new rankings.
Read more about this success
“This is cutting edge technology, developed in Dundee. Its value is recognised worldwide.”

Professor Andrew Hopkins, Chief Executive, Exscientia

Our spin-outs

Read about some of our success stories...


Exscientia is at the forefront of Artificial Intelligence (AI)-driven drug discovery and design and world-leaders in their field. Formed in 2012, the company were the first to automate drug design, and have since become a leading pharmatech company.

Read more about Exscientia

Amphista Therapeutics

Developing drugs using ground-breaking targeted protein degradation technology from the laboratory of Professor Alessio Ciulli. It is backed by Advent Life Sciences, one of the leading trans-Atlantic venture capital investors.


STAR-Dundee are an engineering space company focussed on spacecraft onboard data-handling technology. The company delivers a comprehensive range of test and development equipment chip designs and IP cores to the world’s space agencies and international aerospace industry.

Read more about STAR-Dundee

MyWay Digital Health

MyWay Digital Health aims to improve the lives of people living with diabetes through data-driven technology solutions. They do this by supporting clinicians with intelligent, integrated patient management systems for diabetes and by helping patients manage their own condition.

Read more about MyWay Digital Health

Whole Life Consultants

WLC Ltd conduct first-class contract research, solving problems others cannot solve. Drawing on cutting-edge research they offer consultancy in niche markets where they have specialist and highly developed expertise.

Read more about Whole Life Consultants


Ubiquigent Limited is a specialist developer and supplier of Drug Discovery Services, high quality Research Tools and Chemistry to the life science research community worldwide.

Read more about Ubiquigent


Developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.

DC Biosciences Ltd

DC Biosciences Ltd provides pharmaceutical and biotech companies with proteomics services to accelerate the development of safer drugs.

Glencoe Software Ltd

Design and production of software and data storage solutions for biological imaging. Glencoe Software is the commercial arm of the Open Microscopy Environment, a community-led, open source data specification and software development consortium.

In4Derm Ltd

Specialises in the discovery of drugs, which are safe and effective, for the treatment of skin diseases including eczema, non-melanoma skin cancers and orphan skin diseases.

Platinum Informatics

Developing powerful new software solutions for managing complex informatics and multidimensional proteomics scientific datasets in a wide range of laboratory and industrial environments.

Ten Bio Ltd

Advancing in vitro science by providing advanced ex vivo human skin models that closely mimic intact living skin. Their technology offers users a reliable alternative to animal testing and thus a more ethical and economic route to market.


Enables and supports ubiquitin system focused drug discovery by developing novel compounds targeted towards ubiquitin system proteins as well providing access to a suite of comprehensive research services and reagents.